Home/Filings/4/0001062993-23-015050
4//SEC Filing

Anderson David W 4

Accession 0001062993-23-015050

CIK 0001842939other

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 8:32 PM ET

Size

12.4 KB

Accession

0001062993-23-015050

Insider Transaction Report

Form 4
Period: 2023-07-14
Transactions
  • Award

    Stock Option (right to buy)

    2023-07-14+16,28516,285 total
    Exercise: $1.79Exp: 2026-07-16Common Stock (16,285 underlying)
  • Award

    Stock Option (right to buy)

    2023-07-14+19,91019,910 total
    Exercise: $1.79Exp: 2027-06-20Common Stock (19,910 underlying)
  • Award

    Stock Option (right to buy)

    2023-07-14+8,5098,509 total
    Exercise: $2.27Exp: 2029-07-19Common Stock (8,509 underlying)
  • Award

    Stock Option (right to buy)

    2023-07-14+32,17332,173 total
    Exercise: $2.11Exp: 2031-09-23Common Stock (32,173 underlying)
Footnotes (4)
  • [F1]Options are fully vested and exercisable.
  • [F2]Options to purchase 8,509 shares of common stock of Legacy Carmell (as defined below) granted on July 19, 2019, which vest as follows: (i) 25% vested on July 19, 2020, July 19, 2021 and July 19, 2022 and the remaining 25% will vest on July 19, 2023.
  • [F3]Options to purchase 32,173 shares of common stock of Legacy Carmell granted on September 23, 2021, which vest as follows: 25% vested on September 23, 2022 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date.
  • [F4]On July 14, 2023, Alpha Healthcare Acquisition Corp. III ("ALPA") consummated a business combination (the "Business Combination") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation ("Merger Sub") and Carmell Regen Med Corporation, a Delaware corporation ("Legacy Carmell"), ALPA changed its name to "Carmell Therapeutics Corporation" and Merger Sub merged with and into Legacy Carmell. As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation.

Issuer

ALPHA HEALTHCARE ACQUISITION CORP III

CIK 0001842939

Entity typeother

Related Parties

1
  • filerCIK 0001304554

Filing Metadata

Form type
4
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 8:32 PM ET
Size
12.4 KB